Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC
Clinical trial NCT06699459 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06699459
- Sponsor
- Sir Run Run Shaw Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-14
- Primary completion
- 2026-11-15
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.